| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +520 | +5% | $0.000000 | 10,961 | 01 Sep 2023 | Direct | F1, F2 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $71,028 | -180 | -1.6% | $394.60 | 10,781 | 01 Sep 2023 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +329 | +3.1% | $0.000000 | 11,110 | 01 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $44,984 | -114 | -1% | $394.60 | 10,996 | 01 Sep 2023 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +361 | +3.3% | $0.000000 | 11,357 | 02 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $49,325 | -125 | -1.1% | $394.60 | 11,232 | 02 Sep 2023 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +495 | +4.4% | $0.000000 | 11,727 | 03 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $67,871 | -172 | -1.5% | $394.60 | 11,555 | 03 Sep 2023 | Direct | |
| transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +600 | +5.2% | $0.000000 | 12,155 | 04 Sep 2023 | Direct | F1 |
| transaction | BIO | Bio-Rad A Common Stock | Tax liability | $108,515 | -275 | -2.3% | $394.60 | 11,880 | 04 Sep 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -520 | -25% | $0.000000 | 1,562 | 01 Sep 2023 | Bio-Rad A Common Stock | 520 | $0.000000 | Direct | F3, F4 |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -329 | -33% | $0.000000 | 659 | 01 Sep 2023 | Bio-Rad A Common Stock | 329 | $0.000000 | Direct | F3, F5 |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -361 | -50% | $0.000000 | 361 | 02 Sep 2023 | Bio-Rad A Common Stock | 361 | $0.000000 | Direct | F3, F6 |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -495 | -50% | $0.000000 | 495 | 03 Sep 2023 | Bio-Rad A Common Stock | 495 | $0.000000 | Direct | F3, F7 |
| transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -600 | -100% | $0.000000* | 0 | 04 Sep 2023 | Bio-Rad A Common Stock | 600 | $0.000000 | Direct | F3, F8 |
| Id | Content |
|---|---|
| F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
| F2 | Includes 31.8970 and 24.7960 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2023 and 06/30/2023. |
| F3 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
| F4 | On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F5 | On September 1, 2021, the reporting person was granted 1,317 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F6 | On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F7 | On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |
| F8 | On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |